Global Single-use Bioprocessing System Market 2017-2021

  • ID: 4225800
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
until May 31st 2018
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Danaher
  • Eppendorf
  • GE Healthcare
  • Merck
  • Saint-Gobain.
  • Sartorius
  • MORE

The single-use bioprocessing systems market is rapidly evolving. It focuses on developing disposable bioprocessing equipment and accessories for manufacturing of biopharmaceutical products. Bioprocess is a technique that produces biological materials such as a genetically engineered microbial strain for commercial use. For example, commercially useful chemicals are produced through bioprocess techniques such as microbial fermentation or degradation. The traditional approaches in bioprocessing involve stainless steel equipment that are not just difficult to maintain but also time-consuming and costly.

The analysts forecast the global single-use bioprocessing system market to grow at a CAGR of 7.83% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global single-use bioprocessing system market for 2017-2021. To calculate the market size, the report considers the revenue generated from retail sales of Key vendors to end-users such as pharmaceutical companies, CROs/CMOs, biotech companies, and academic and research institutions.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Single-Use Bioprocessing System Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  •  Danaher
  •  GE Healthcare
  •  Merck
  •  Sartorius
  •  Thermo Fisher Scientific

Other prominent vendors

  •  Broadley-James Corporation
  •  Eppendorf
  •  Saint-Gobain

Market drivers

  •  Single-use technology (SUT) combats global drug shortage problem.
  •  For a full, detailed list, view the full report

Market challenges

  •  Risk of leachables and extractables from plastics used in disposable systems.
  •  For a full, detailed list, view the full report

Market trends

  •  Increasing adoption of single-use bioprocessing in pre-clinical and commercial stages.
  •  For a full, detailed list, view the full report

Key questions answered in this report

  •  What will the market size be in 2021 and what will the growth rate be?
  •  What are the key market trends?
  •  What is driving this market?
  •  What are the challenges to market growth?
  •  Who are the key vendors in this market space?
  •  What are the market opportunities and threats faced by the key vendors?
  •  What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.

READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Danaher
  • Eppendorf
  • GE Healthcare
  • Merck
  • Saint-Gobain.
  • Sartorius
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Key market highlights
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by application
  • Market overview
  • mAB production
  • Vaccine production
  • Plant cell cultivation
  • PSCTs
  • Others
PART 07: Market segmentation by product type
  • Market overview
  • Bags and mixers
  • Bioreactors and fermenters
  • Filtration devices and sampling systems
  • Bioprocess containers
  • Tubing systems (connectors/pipes)
  • Others
PART 08: Market segmentation by end-users
  • Market overview
  • Pharmaceutical companies
  • CROs & CMOs
  • Biotechnology companies
  • Academic and research institutions
PART 09: Geographical segmentation
  • Market overview
  • Americas
  • EMEA
  • APAC
PART 10: Decision framework

PART 11: Drivers and challenges
  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments
PART 12: Market trends
  • Increasing adoption of single-use bioprocessing in pre-clinical and commercial stage
  • Emergence of downstream disposables
  • SUT aiding continuous bioprocessing
PART 13: Vendor landscape
  • Competitive scenario
PART 14: Key vendor analysis
  • Danaher
  • GE Healthcare
  • Merck
  • Sartorius
  • Thermo Fisher Scientific
  • Other prominent vendors
PART 15: Appendix
  • List of abbreviations
Exhibit 01: Advantages of single-use technologies over stainless steel technology
Exhibit 02: Global single-use bioprocessing systems market ($ billions)
Exhibit 03: Ongoing trends in biopharmaceutical industry impacting the adoption of single-use technologies
Exhibit 04: Five forces analysis
Exhibit 05: Global single-use bioprocessing systems market by application 2016-2021 (%)
Exhibit 06: Global single-use bioprocessing systems market for mAB production 2016-2021 ($ millions)
Exhibit 07: Global single-use bioprocessing systems market for vaccine production 2016-2021 ($ millions)
Exhibit 08: Global single-use bioprocessing systems market for plant cell cultivation 2016-2021 ($ millions)
Exhibit 09: Global single-use bioprocessing systems market for PSCTs 2016-2021 ($ millions)
Exhibit 10: Global single-use bioprocessing systems market for other applications 2016-2021 ($ millions)
Exhibit 11: Global single-use bioprocessing systems market by product type 2016-2021 (%)
Exhibit 12: Global single-use bags and mixers market 2016-2021 ($ millions)
Exhibit 13: Global SUBs and fermenters market 2016-2021 ($ millions)
Exhibit 14: Global single-use filtration devices and sampling systems market 2016-2021 ($ millions)
Exhibit 15: Global single-use bioprocess containers market 2016-2021 ($ millions)
Exhibit 16: Global single-use tubing systems market 2016-2021 ($ millions)
Exhibit 17: Global single-use others market 2016-2021 ($ millions)
Exhibit 18: Global single-use bioprocessing systems market by end-users 2016 and 2021
Exhibit 19: Pharmaceutical companies in global single-use bioprocessing systems market 2016-2021 ($ millions)
Exhibit 20: CROs and CMOs in global single-use bioprocessing systems market 2016-2021 ($ millions)
Exhibit 21: Biotech companies in global single-use bioprocessing systems market 2016-2021 ($ millions)
Exhibit 22: Academic and research institutions in global single-use bioprocessing systems market 2016-2021 ($ millions)
Exhibit 23: Global single-use bioprocessing systems market by geography 2016-2021
Exhibit 24: Single-use bioprocessing systems market in Americas 2016-2021 ($ billions)
Exhibit 25: Single-use bioprocessing systems market in EMEA 2016-2021 ($ billions)
Exhibit 26: Single-use bioprocessing systems market in APAC 2016-2021 ($ billions)
Exhibit 27: Recent M&As in the single-use bioprocessing systems market
Exhibit 28: Impact of drivers
Exhibit 29: Impact of challenges
Exhibit 30: Advantages of implementing single-use bioprocessing systems
Exhibit 31: Strategic success factor of consideration for companies
Exhibit 32: Danaher: Profile
Exhibit 33: Danaher: Strength analysis
Exhibit 34: Danaher: Strategy assessment
Exhibit 35: Danaher: Opportunity assessment
Exhibit 36: GE Healthcare: Profile
Exhibit 37: GE Healthcare: Strength analysis
Exhibit 38: GE Healthcare: Strategy assessment
Exhibit 39: GE Healthcare: Opportunity assessment
Exhibit 40: Merck: Profile
Exhibit 41: Merck: Strength analysis
Exhibit 42: Merck: Strategy assessment
Exhibit 43: Merck: Opportunity assessment
Exhibit 44: Sartorius: Profile
Exhibit 45: Sartorius: Strength analysis
Exhibit 46: Sartorius: Strategy assessment
Exhibit 47: Sartorius: Opportunity assessment
Exhibit 48: Thermo Fisher Scientific: Profile
Exhibit 49: Thermo Fisher Scientific: Strength analysis
Exhibit 50: Thermo Fisher Scientific: Strategy assessment
Exhibit 51: Thermo Fisher Scientific: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Danaher
  • Eppendorf
  • GE Healthcare
  • Merck
  • Saint-Gobain.
  • Sartorius
  • MORE

The following companies are recognised as the key players in the global single-use bioprocessing system market: Danaher, GE Healthcare, Merck, Sartorius, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Broadley-James Corporation, Eppendorf, and Saint-Gobain.

Commenting on the report, an analyst from the research team said: “One trend in market is increasing adoption of single-use bioprocessing in pre-clinical and commercial stage. Single-use bioprocess systems have currently established themselves as the accepted choice at both the pre-clinical and bioproduction stage. Biopharmaceutical companies are increasingly accepting these systems as a trusted alternative at the commercial stage to accelerate the production process.”

According to the report, one driver in market is SUT combats global drug shortage problem. The biopharmaceutical industry is shifting toward SUTs to combat the global drug shortage. Companies struggle to meet clinical trial timelines and invariably suffer losses, which could be avoided. The growing evidence of sterility, along with regulatory organizations encouraging pharma companies to switch to single-use technologies, hints toward a transition. Companies that have integrated and shifted toward a single-use system have expressed their satisfaction in terms of lower costs, reduced overall contamination rates, and enhanced production throughput efficiency. While using SUTs, companies spend lesser time with disassembly and clean-up of the system, resulting in a quicker turnaround time for new batches of medications. SUT allows for continuous manufacturing and saves the companies production time. This translates to huge cost savings, which the pharma companies can use in other aspects of drug development. Thus, single-use technology is the most cost-efficient solution to increase rapidity in drug development, support larger batches of production, and achieve a quicker time to market the solutions.

Further, the report states that one challenges in market is lack of standardization across suppliers. The absence of standardization in equipment is a key challenge for end-users in the single-use bioprocessing systems market, despite the advantages of cost and faster implementation. Generally, components sourced from one supplier cannot be used with components from another due to lack of compatibility and different materials used by suppliers to manufacture the same equipment. This is forcing vendors to stick to one supplier or purchase duplicate versions of same components, which is increasing their inventory management costs. Some suppliers have stated the reasons for the absence of standardization, which is because vendors are customizing equipment according to their respective needs, which leads to additional charge from the supplier's side. For example, a customized assembly would cost more in comparison to off-the-shelf assembly when solutions have to be adjusted to a certain manufacturing site.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Note: Product cover images may vary from those shown
5 of 5
  • Danaher
  • GE Healthcare
  • Merck
  • Sartorius
  • Thermo Fisher Scientific
  • Broadley-James Corporation
  • Eppendorf
  • Saint-Gobain.
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll